CTI BioPharma, Fred Hutch Establish $1.5 Mln Endowment Fund For Cancer Research

(RTTNews) - CTI BioPharma Corp. (CTIC) and Fred Hutchinson Cancer Research Center announced Thursday the establishment of a new $1.5 million research endowment fund, The CTI BioPharma International Postdoctoral Research Fellowship, to support innovative blood-related cancer research.

The fund is intended to foster international collaboration in translational research and support advancements in the fields of hematology and immunobiology.

This fellowship and endowment will provide seed funding to support the research efforts of promising, young physician researchers from around the world.

Fred Hutch will receive endowment funding over three years to identify and select proposed research projects from medical researchers currently working at international institutions based outside of the U.S.

Both CTI BioPharma and other institutions or organizations can donate additional funding to the endowment at any time, per the approval of Fred Hutch.

The CTI BioPharma fellowship and endowment fund is in memory of Donnall Thomas, a pioneering scientist and Nobel Prize recipient who had a profound and positive impact on the co-founders of CTI BioPharma, Bianco and Jack Singer, chief scientific officer and global head of Translational Medicine.